Phathom Pharmaceuticals, Inc. PHAT Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s operating lease liabilities?
- Phathom Pharmaceuticals, Inc. (PHAT) reported operating lease liabilities of $1.96M in Q1 2026.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s operating lease liabilities has grown at a 5.8% compound annual growth rate (CAGR), from $1.56M to $2.07M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.